Read the full judgment text of HCMP 001418/2007 on BabelCite. This High Court CFI judgment was delivered on 23 October 2007.
1. This petition was presented by TA Therapeutics Limited (“the Company”) on 30 July 2007 pursuant to section 59 of the Companies Ordinance, Cap. 32. The application is for confirmation of a proposed reduction of share capital involving the diminution of liability in respect of unpaid share capital, which comes within section 59(3). The Company seeks confirmation of the reduction of the liability of Biotechnology Research Corporation Limited (“BRC”), a member of the Company, to pay US$5 millio